Wednesday
October 18, 2023 |
|
|
|
|
8:00 am - 12:00 pm |
CMCN Certification Exam -
Additional fee applies. Eligibility and application must be
approved by September 21, 2023. For more information, please
email or call with questions
jbeilhart@aamcn.org or 804-527-1905 |
|
10:30 am - 7:30 pm |
Pre Registration |
|
|
|
12:30 pm - 5:00 pm |
AAMCN Pre Conference |
|
|
|
11:00 am - 5:00 pm |
Exhibit Hall Set Up |
|
|
|
|
|
|
|
Thursday
October 19,
2023 |
|
|
|
7:00 am - 7:40 am |
Hot Breakfast in the Exhibit Hall |
|
|
7:40 am - 7:45 am |
Welcome & Opening Remarks:
Doug Chaet, Founder & Chairman, AAIHDS |
|
|
7:45 am - 8:45 am |
Keynote - 2023 – Historic
Healthcare Transformation
Jacque Sokolov, MD, President and Chairman, SSB Solutions |
|
|
8:45 am - 9:30 am |
Break in Exhibit Hall |
|
|
|
|
|
|
|
|
|
BUSINESS TRACK |
HEALTH MANAGEMENT |
ONCOLOGY |
|
9:30 am - 10:30 am |
Optimizing Health Plan
Medical Expenses: Strategies for Addressing Rising Costs and
Improving Financial Sustainability
David Gregory, MPA, FACHE, Principal and Healthcare
Industry Leader, Baker Tilly |
Advancing Patient-Centric
Strategies to Optimize Menopause Care: Exploring the
Management of Vasomotor Symptoms
Ekta Kapoor, MBBS, FACP, Associate Professor of
Medicine, Assistant Director, Mayo Clinic Center for Women’s
Health |
Managed Care
Considerations in the Treatment and Management of Ovarian
Cancer: Expert Strategies on the Evolving Role of PARP
Inhibitors
Richard T. Penson, MD, MRCP, Clinical Director,
Medical Gynecologic Oncology, Associate Professor, Harvard
Medical School, IRB Chair, Dana Farber Harvard Cancer Center
|
|
10:30 am - 11:30 am |
Your Avatar Will See You
Now: Harnessing Data, AI and Technology to Unlock Value
Theresa Hush, CEO, Roji Health Intelligence |
Informed Managed Care
Decision-Making in the Management of Hereditary Angioedema (HAE):
Optimizing Clinical and Economic Outcomes in an Evolving
Paradigm
Marc Riedl, MD, MS, Professor of Medicine, Clinical
Director – US HAEA Angioedema Center, University of
California, San Diego |
New Horizons in the
Treatment and Management of Endometrial Cancer: Leveraging
Immunotherapy for Improved Clinical and Economic Outcomes
Dario R. Roque, MD, Assistant Professor, Gynecologic
Oncology, Department of Obstetrics & Gynecology, Feinberg
School of Medicine at Northwestern University |
|
11:30 am - 12:30 pm |
Lunch in the Exhibit Hall |
Lunch in the Exhibit Hall |
Lunch in the Exhibit Hall |
|
12:30 pm - 1:30 pm |
Strategies Learned From a
Half-Century of Healthcare Trends (and Counting)
Max Reiboldt, CPA, President/CEO, Coker Group and
Thomas D. Anthony, Esquire, Frost Brown Todd LLC |
Integrating Novel
Approaches in Psoriasis Management: Closing the Gaps with
Innovative Treatment Strategies
April W. Armstrong, MD, MPH, Professor and Chief,
Division of Dermatology, University of California Los
Angeles |
A New Era in the Treatment
of Prostate Cancer: Integrating Targeted Therapies to
Optimize Outcomes
Robert Dreicer, MD, MS, Section Head Medical
Oncology, Deputy Director, University of Virginia Cancer
Center, Co-Director
|
|
1:30 pm - 2:30 pm |
Achieving Health Equity:
Beyond Addressing Social Determinants of Health
Robert Kritzler, MD, Physician Principal, and
Kristina Ramos-Callan, Senior Consultant, Health Management
Associates |
New Horizons in the
Treatment and Management of Alzheimer’s Disease: Managed
Care Considerations on Role of New and Emerging Therapies
Richard S. Isaacson, MD, Director, FAU Center for
Brain Health, Schmidt College of Medicine, Florida Atlantic
University |
Implementing New Data and
Evolving Standards in HER2-Positive Advanced Breast Cancer:
Applying the Latest Evidence to Improve Outcomes
Gary Owens, MD, President, Gary Owens Associates |
|
2:30 pm - 3:00 pm |
Break in Exhibit Hall |
Break in Exhibit Hall |
Break in Exhibit Hall |
|
3:00 pm - 4:00 pm |
Reducing Cost While
Improving Health Outcomes: Strategies to Increase Adherence
to Treatment Recommendations
Mark Carlson, PsyD, Owner/CEO, Mental Health Systems |
Novel HIV Prevention and
Management Strategies: Optimizing PrEP and ART Managed Care
Decision Making for Improved Outcomes
Timothy Wilkin, MD, MPH, Assistant Professor of
Medicine, Division of Infectious Diseases, Weill Medical
College of Cornell University |
Innovative Approaches in
the Management of Chronic Lymphocytic Leukemia (CLL)
John Allan, MD, Assistant Professor of Medicine,
Division of Hematology and Medical Oncology, Weill Cornell
Medicine |
|
4:00 pm - 5:00 pm |
How to Dig Your Way Out of
a Risk Deal Going Bad
Cliff Frank, President, Healthcare Management
Solutions and I. David Kibbe, MHA, Senior Advisor, Cone
Health |
New Horizons in the
Treatment and Management of Chronic Cough: Key Managed Care
Considerations on the Role of New and Emerging Therapies
Peter Dicpinigaitis, MD, FCCP, Professor of Medicine,
Albert Einstein College of Medicine, Division of Critical
Care Medicine, Montefiore Medical Center, Director,
Montefiore Cough Center |
New Insights into the
Management of Metastatic Bladder Cancer: Expert Strategies
and Treatment Considerations for Managed Care
Jones T. Nauseef, MD, PhD, Assistant Professor of
Medicine, Division of Hematology & Medical Oncology, Sandra
and Edward Meyer Cancer Center, Weill Cornell Medicine |
|
5:00 pm - 6:30 pm |
Reception in Exhibit Hall |
Reception in Exhibit Hall |
Reception in Exhibit Hall |
|
|
|
|
|
Friday
October 20,
2023 |
|
|
|
7:00 am - 7:40 am |
Hot Breakfast in the Exhibit Hall |
|
|
|
7:40 am - 7:45 am |
Opening Remarks |
|
|
7:45 am - 8:45 am |
Keynote - Healthcare
Disruptors: A New Era of Provider Transformation
John Harris, Managing Director, Veralon |
|
|
8:45 am - 9:30 am |
Break in Exhibit Hall |
Break in Exhibit Hall |
Break in Exhibit Hall |
|
|
|
|
|
|
|
BUSINESS TRACK |
HEALTH MANAGEMENT |
ONCOLOGY |
|
9:30 am - 10:30 am |
Health System Leverages
Post-Acute Data Transparency to Drive Clinical Performance
and Reduce Cost
Lori
Calderone, Director, St Joseph’s Health Partners CIN |
Addressing the Barriers to
Optimal Adolescent and Adult Immunizations: Enhancing
Confidence to Overcome Suboptimal Vaccination Practices
David J. Cennimo, MD, VA New Jersey Health Care
System, Associate Professor of Medicine & Pediatrics,
Rutgers New Jersey Medical School |
Keeping Pace with Rapid
Advancements in the Treatment and Management of Multiple
Myeloma
Ravi Vij, MD, MBA, Professor of Medicine, Division of
Medical Oncology, Washington University School of Medicine |
|
10:30 am - 11:30 am |
Leading Populations to
Health in 3 Steps
Don Forrester, MD, FACPE, Clinical Catalyst,
Forrester and Associates |
Expert Strategies in the
Treatment and Management of Epilepsy: Insights on Novel
Evidence and Patient Perspectives
Jay Salpekar, MD, Director, Neuropsychiatry in Epilepsy
Program, Kennedy Krieger Institute, Associate Professor of
Psychiatry and Neurology, Johns Hopkins University School of
Medicine
|
Informed Managed Care
Decision-Making in the Management of HER2-Negative Breast
Cancer: Optimizing the Impact of Targeted Therapy for
Improved Outcomes
Neelima Vidula, MD, Assistant Professor of Medicine,
Harvard Medical School, Breast Medical Oncologist,
Massachusetts General Hospital
|
|
11:30 am - 12:30 pm |
Lunch in the Exhibit Hall |
Lunch in the Exhibit Hall |
Lunch in the Exhibit Hall |
|
|
|
HEALTH MANAGEMENT |
GBEMTI |
|
12:30 pm - 1:30 pm |
|
Incorporating Biosimilars
into the Clinical Landscape: Expert Insights for Managed
Care Considerations
Allan Gibofsky, MD, JD, Professor of Medicine, Weill
Cornell Medicine, Co-Director, Clinic for Inflammatory
Arthritis, Hospital for Special Surgery
|
Recent Advances in the
Treatment and Management of Advanced Non-Small Cell Lung
Cancer (NSCLC)
Gary Owens, MD, President, Gary Owens Associates |
|
1:30 pm - 2:30 pm |
|
Informed Managed Care
Decision-Making in the Management of Acute Myeloid Leukemia
(AML): Optimizing Clinical and Economic Outcomes in an
Evolving Paradigm
Amir T. Fathi, MD, Program Director, Center for
Leukemia, Massachusetts General Hospital Cancer Center,
Associate Professor of Medicine, Harvard Medical School |
|
|
2:30 pm - 2:40 pm |
|
Break |
Break |
|
2:40 pm - 3:40 pm |
|
Targeting New Strategies
in Narcolepsy and Idiopathic Hypersomnia: Novel Approaches
to Diagnosis and Treatment
Anne Marie Morse, DO, FAASM, Director, Pediatric
Sleep Medicine, Clinical Associate Professor, Geisinger
Commonwealth School of Medicine, Geisinger Medical Center |
|
|
3:40 pm - 4:40 pm |
|
Informed Managed Care
Decision-Making in the Management of Worsening Heart
Failure: Optimizing Outcomes with New and Emerging Therapies
Alanna Morris MD, MSc, Associate Professor of
Medicine, Division of Cardiology, Director of Heart Failure
Research, Emory University Clinical Cardiovascular Research
Institute |
|
|
|
|
|
|
|
|
Agenda is subject to change |
|
|
